TGA: September 2026 updates to the list of decisions for Australian manufacturers licensed by the TGA
New treatment option on the PBS for locally advanced or metastatic bladder cancer – Astellas Pharma Australia
Federal Court: Commissioner of the NDIS Quality and Safeguards Commission v Peters (Penalty and Other Relief) [2026] FCA 1241
Government funds medicine for approximately 10,000 eligible Australians with certain advanced or metastatic cancers – Ethical Strategies on behalf of MSD Australia & New Zealand
AIHW: National Drug Strategy Household Survey 2025: Tobacco, e-cigarettes and other nicotine insights